Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAY 1817080 vs elagolix vs placebo in symptomatic endometriosis
CTR20210645Phase 2Terminated
- Sponsor
- Bayer
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of eliapixant in endometriosis, sponsored by Bayer. Started Mar 2021; status: terminated.
02
Drugs
eliapixant
03
Conditions
endometriosis
Beyond the preview
Go deeper on CTR20210645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210645.